Facebook
X
LinkedIn
ForwardQ&A Session Cancer, Pain, and Opioid Use Disorder
Q&A Session Cancer, Pain, and Opioid Use Disorder enduring module is a recording from the live Regularly Scheduled Series dated June 22, 2023. If you claimed credit for this session at the live meeting, you should not claim credit for this module.
Almost two million Americans are diagnosed with a new cancer and 33% will experience moderate or severe pain. Patients who are also diagnosed with an Opioid Use Disorder can receive appropriate cancer care, including pain management when oncology and addiction teams work together.
Target Audience
Physicians, Nurses, Nurse Practitioners, Physician Assistants, Pharmacists, Social Workers
Learning Objectives
Upon completion of this activity, participants will be able to:
- Review the incidence of cancer in different populations, treatment options, and related adverse effects.
- Outline the pillars of cancer pain management and appropriate screening tools for opioid use disorder.
- Apply knowledge of cancer care and pain management to care for patients with opioid use disorder.
Marianne Carter, PharmD
Clinical Pharmacy Specialist
Palliative Care and Pain Management
UK HealthCare
Lexington, Kentucky
In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Available Credit
- 1.25 ACPE
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This knowledge-based activity will award 1.25 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number: JA0000312-0000-23-089-H08-P
- 1.25 AMA PRA Category 1 Credit™
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This Enduring activity is designated for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
- 1.25 ANCC (UK Healthcare CECentral)
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.25 nursing contact hour(s).
- 1.25 ASWB
As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course.
Social workers completing this course receive 1.25 clinical continuing education credit(s).